In vitro effects of cholesteryl butyrate solid lipid nanospheres as a butyric acid pro-drug on melanoma cells: Evaluation of antiproliferative activity and apoptosis induction

Literature data show that butyric acid derivatives bear a dose-dependent di fferentiative anti-proliferative activity on cancer cell lines and that apo ptosis induction may play a major role. Although it was recently shown that solid lipid nanospheres (SLNs) are a suitable tool for several in vivo dru g administration routes, there is little available information on melanoma cell lines. This study was aimed at evaluating the anti-proliferative and a poptotic in vitro effects of cholesteryl butyrate (chol-but) SLNs on melano ma cells. Increasing concentrations of chol-but SLNs were used to test two melanoma cell lines. Both cell lines were treated with Na-butyrate (Na-but) and chol-but SLNs for viability. Those tested with chol-but SLNs were more effective than Na-butirate (3 to 72 h). The apoptotic effects of chol-but SLNs were evaluated between 3 and 72 h by annexin-V (ANX-V)/propidium iodid e (PI) staining and the antiproliferative effect by PI staining. Apoptosis anti-proliferative-regulatory proteins as bcl-2, Fas/APO1 (CD95) and PCNA ( PC10) were also investigated. Flow cytometric analyses evidenced a G(0/1)-S transition block and a `sub-G(0/1)' apoptotic peak from 0.5 to 1.0 mM buty ric acid. In ANX-V/PI flow cytometric staining, a dose- and time-dependent increase in the apoptotic cell percentage (ANX-V+) coupled with a down-regu lation of PC10 and bcl-2 and a parallel up-regulation of Fas/APO1 (CD95) we re found in both lines started after 3 to 24 h of chol-but SLNs treatment. Results show that chol-but SLNs exerts a dose/time-dependent effect in mela noma cell apoptosis induction between 3 and 24 h and a dose but not time-de pendent effect after 24 h of treatment.